EWM
WST icon

Empirical Wealth Management’s West Pharmaceutical WST Stock Holding History

Empirical Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$852K Buy
2,373
+1,137
+92% +$348K 0.01% 453
2026
Q1 		$310K Buy
+1,236
New +$308K 0.01% 779

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Empirical Wealth Management's WST Position: Q2 2026 in Review

Empirical Wealth Management increased its West Pharmaceutical (WST) stake by 92% in Q2 2026, buying an estimated $348K and bringing the position to 2,373 shares worth $852K. The position accounts for 0.01% of the portfolio, ranked #453.

Empirical Wealth Management first reported a position in WST in Q1 2026 and has held it in 2 quarters since. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Empirical Wealth Management held 2,373 shares of West Pharmaceutical worth $852K as of Q2 2026.
  • Empirical Wealth Management bought 1,137 West Pharmaceutical shares in Q2 2026, an estimated $348K.
  • West Pharmaceutical made up 0.01% of Empirical Wealth Management's portfolio in Q2 2026, its #453 holding.
  • Empirical Wealth Management first reported a position in West Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.